# Insulin Resistance: Which Tests Help Assess Glucose?

Insulin resistance and prediabetes are related but different. A1c, fasting glucose, and glucose-tolerance testing help assess the glucose picture.

Canonical: https://velri.co/blog/insulin-resistance-biomarkers-behind-stubborn-weight
Publisher: Velri (https://velri.co/about)
Published: 2026-06-14
Updated: 2026-09-30
Editorial policy: https://velri.co/editorial-policy

Insulin resistance means cells respond less effectively to insulin, the hormone that helps glucose enter cells. The pancreas may compensate by making more insulin. If that response no longer keeps glucose in the usual range, prediabetes or diabetes can develop.[1]

Insulin resistance and prediabetes are related, but they are not interchangeable labels.

## Glucose tests answer defined questions

NIDDK notes that direct testing for insulin resistance is mainly used in research. Clinicians commonly evaluate prediabetes with established glucose tests instead:[1]

- **A1c** estimates average blood glucose over about three months.
- **Fasting plasma glucose** measures blood glucose at one point after fasting.
- **An oral glucose tolerance test** measures the response after a glucose drink.

The tests provide different views. The choice and interpretation depend on the clinical question and circumstances.

## Weight does not establish the diagnosis

Excess weight and other factors can raise the risk of insulin resistance, but difficulty losing weight does not prove it is present. Some people with insulin resistance or prediabetes have no obvious symptoms.[1]

A fasting insulin result is also not a universal explanation for stalled weight loss.

## A result needs a next step

A1c can be affected by certain conditions involving red blood cells or hemoglobin. If results do not fit the rest of the picture, another test may be needed.[2]

A useful review explains what was measured, whether a finding needs confirmation, and what follow-up is appropriate.

## Sources
[1] Insulin Resistance & Prediabetes - NIDDK. https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/prediabetes-insulin-resistance
[2] The A1C Test & Diabetes - NIDDK. https://www.niddk.nih.gov/health-information/diagnostic-tests/a1c-test

## About this information
General health information, not personal medical advice, diagnosis or treatment. A prescription is required and is never guaranteed.
Velri is a brand operated by Velri Management LLC, a Nevada limited liability company. Velri is a non-clinical technology and administrative services company. Velri does not provide medical advice, diagnosis, treatment, or pharmacy services, and does not direct the clinical judgment of any provider.
All medical consultations and prescriptions are provided directly by independent provider groups (Online Medical Care, P.C.; TMD of Kansas, P.A.; TMD of Texas, P.A.; and TMD of CA, PC), by a provider licensed in your state. Velri does not employ providers. A prescription is issued only if a provider determines it is clinically appropriate in their independent medical judgment.
All prescription products are dispensed by independent, licensed pharmacies. Velri does not own, operate, or control any pharmacy and does not dispense medication. You may opt out of using a given provider group or pharmacy at any time.
Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
Velri is cash-pay. We do not bill Medicare, Medicaid, or commercial insurance. Refunds and order problems are addressed in the Terms of Use; your rights under applicable law are not limited. State availability and clinical eligibility apply.
Velri and telehealth are not for medical emergencies. If you are experiencing an emergency, call 911.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Care is available to eligible adults 18 and older in 47 states and D.C., United States only.
Notice of Privacy Practices: https://velri.co/privacy/notice-of-privacy-practices
Terms: https://velri.co/legal/terms
Provider group or pharmacy opt-out help: https://velri.co/contact and https://velri.co/standards#trust-support